RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT – Trademark Portfolio
Entity Type: 03
RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 6 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include RAIFFEISEN and RB INTERNATIONAL MARKETS USA. The owner is based in VIENNA.
AM STADTPARK 9
VIENNA 1030 , AT
Showing of trademarks Trademarks
Trademark Classifications
RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT have?
RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 cancelled.
What trademark classes does RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT file in?
RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT's most well-known trademarks?
RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT's registered trademark portfolio includes well-known marks such as RAIFFEISEN and RB INTERNATIONAL MARKETS USA. These are among 4 currently registered trademarks in the portfolio.
What is RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT's trademark registration success rate?
RAIFFEISEN ZENTRALBANK OESTERREICH AKTIENGESELLSCHAFT has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.